BAY 1830839 (BAY 1830839) | 合法醫療器材資訊網
Loading...8989.Updated04-Dec-2020.Close.BayerBAY1830839.ConsensusChart.AnnualSales.QuarterlyPerformance.BAY1830839T&Ds.FirstGlance.
Loading... 8989. Updated 04-Dec-2020. Close. Bayer BAY 1830839. Consensus Chart. Annual Sales. Quarterly Performance. BAY 1830839 T&Ds. First Glance.
bay-1834845 bayer pipeline bay1830839 pf-06650833 bayer pipeline irak4 inhibitor irak4 inhibitor clinical trial bay1834845 structure 華宇藥 新聞 衛署醫器製壹字第003237號 衛署醫器製壹字第003952號 衛部醫器製壹字第008444號 衛部醫器製壹字第008526號 "KURARAY" CLARA SOFT CONTACT LENS “安吉美爾德”巴德依.路明尼斯膽道支架 "叡聲達" 助
Abstract 1887 | 合法醫療器材資訊網
由 M Lange 著作 · 2018 · 被引用 2 次 — BAY 1830839 is a novel small molecule inhibitor of IRAK4 identified by a medicinal chemistry optimization program. Key features of the ... Read More
BAY 1830839 (BAY 1830839) | 合法醫療器材資訊網
Loading... 8989. Updated 04-Dec-2020. Close. Bayer BAY 1830839. Consensus Chart. Annual Sales. Quarterly Performance. BAY 1830839 T&Ds. First Glance. Read More
BAY 1830839 | 合法醫療器材資訊網
BAY 1830839, a small molecule inhibitor of IRAK4 is being developed by Bayer, for the treatment of diffuse large B-cell lymphoma and rheumatoid arthritis (RA). Read More
BAY-1830839|1931994-80-7 | 合法醫療器材資訊網
产品描述. BAY-1830839 , an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor, is being developed by Bayer for the treatment of RA。 化学结构. Read More
BAY1830839: First in Man | 合法醫療器材資訊網
Trial Purpose. The primary objectives of this study are to investigate • the safety and tolerability of increasing single oral doses of BAY 1830839 versus placebo ... Read More
BAY1830839: First in Man | 合法醫療器材資訊網
the safety and tolerability of increasing single oral doses of BAY 1830839 versus placebo ... Arthritis, Rheumatoid, Drug: BAY1830839 Drug: Placebo, Phase 1 ... Read More
Clinical Trial on Arthritis, Rheumatoid | 合法醫療器材資訊網
The primary objectives of this study are to investigate - the safety and tolerability of increasing single oral doses of BAY 1830839 versus placebo under fasted ... Read More
Clinical Trial on Healthy Volunteers | 合法醫療器材資訊網
Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants. Read More
Multiple Dose Escalation Study in a Randomized | 合法醫療器材資訊網
Drugs BAY 1830839 (Primary) ; Methotrexate; Midazolam; Indications Diffuse large B cell ... time_frame: Day -1 period 1 (Dose group 3 of BAY1830839 only). Read More
相關資訊整理
【美堅希堤亞黴酚酸檢驗試劑組】許可證字號:衛部醫器輸字第029817號
器材品名:美堅希堤亞黴酚酸檢驗試劑組許可證字號:衛部醫器輸字第029817號註銷狀態:註銷日期:註銷理由:有效日期:2022/08/04發...